Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition) ›› 2024, Vol. 10 ›› Issue (04): 379-383. doi: 10.3877/cma.j.issn.2096-1537.2024.04.011

• Reviews • Previous Articles     Next Articles

Research progress in sepsis immune disorder: thymic atrophy

Xi Chen1,2, Zongsheng Wu1,2, Mingzhu Zheng1,2, Haibo Qiu1,2,()   

  1. 1.Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China
    2.School of Medicine, Southeast University, Nanjing 210009, China
  • Received:2023-09-06 Online:2024-11-28 Published:2025-01-20
  • Contact: Haibo Qiu

Abstract:

One of the major causes of death in critically ill patients is sepsis, which results from a dysregulated immune response to infection.Both physiological and pathological development of thymus atrophy impairs body immune function.Multiple studies have shown that sepsis also leads to dramatically thymic atrophy, mainly manifested by increased apoptosis of thymocytes and damage of thymic epithelial cells, which is one of the important mechanisms of immune dysfunction in sepsis.More importantly, reversible recovery of thymus function may be closely related to prognosis of sepsis patients.An in-depth understanding of the mechanisms of acute thymic atrophy in sepsis and the development of related strategies to promote thymic recovery may provide new insights for sepsis immunotherapy.

Key words: Sepsis, Thymic atrophy, Immune dysfunction

京ICP 备07035254号-19
Copyright © Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 010-51322627 E-mail: ccm@cma.org.cn
Powered by Beijing Magtech Co. Ltd